Counterfeiting is a serious threat to health, life and business in life-critical sectors such as pharmaceuticals, personal care or automobile sector, and agro-products. Current labels such as holograms and bar-codes can be replicated and affixed to duplicate products.
This project proposes the development of low-cost, anti-counterfeiting labels that are tamper- proof, cannot be cloned and can be used to verify the authenticity of the product using a low-end smartphone, without requiring any form of communication. The technology is based on a proprietary three-dimensional tag (patent filed) that has random patterns (physically un- clonable function). Subsequently, highly complex image processing and math allow offline verification using a mobile phone. The technology combines materials science with digital and mobile technology to offer a product that enables a user to authenticate a product before buying.
5G small cell is a new development and there is no established solution. Current alternate solutions for 10W small cell is to use pin diode which consumes a large amount of current and requires high voltage.
5G is a key technology for mobile communication, IoT and automotive applications. Its implementation will require deployment of a large number of small cells (hundreds of thousands) in countries like India or the United States. There are four components in the block - power amplifier (PA), low noise amplifier (LNA), a protection switch and a circulator. The goal of this project is to develop the LNA using both Gallium Nitride (GaN) and Gallium Arsenide (GaAs) technologies. Novelty in this approach is the use of GaN and GaAs technologies in a cost-effective way on a module. The aim is to develop low-cost 5G small-cell front end, so that it can be widely deployed in cities and small towns.
As a result of stroke, many patients experience upper extremity motor deficit that immensely affects the quality of life, independence and employment of the individual. The current methods available for rehabilitation are both inadequate and expensive.
There is a definite need for an intensive and engaging rehabilitation therapy for individuals with upper extremity motor deficit at the clinic and at home. This can minimize the burden on the therapists without compromising on the quality of therapy. The project proposes a low- cost rehabilitation device that allows for intensive, interactive and engaging therapy with a full range of motion with appropriate multi-sensory biofeedback, and tracking capabilities.The device would enable individuals with upper-limb impairment to perform game-based bilateral and unilateral rehabilitation for restoring motor function.
Patients of renal failure are dependent on dialysis for survival – the process is cumbersome, time and money consuming and not available everywhere.
The proposal aims at developing a wearable, simple and safe, anytime/anywhere Peritoneal Dialysis Cycler (PDC). Use of Recyclable Membranes (a patent applied nanotechnology cum proprietary chemicals based urea/creatinine clearance) is anticipated to cut costs down to INR 10,000 per month per patient. The project aims to reduce the cost by 5x, while reducing the timing from twelve hours to six/eight hours of fully automatic dialysis. The PDC is wearable, thus allowing patients to carry out their work without any intervention or worry. Advantages of the technology include reduced risk of infection, better patient management and preventive care through an online Patient Management System. The Mobile App controls let patients manage dialysis on their own.
In developing countries where health resources are limited, advanced chronic wound care management is costly and most times inaccessible for many patients. Specifically for diabetic patients, there is a heavy reliance on simple gauzes as the current method of treatment for their chronic foot ulcers. This ineffective method only provides temporary relief of pain, leads to low patient compliance, and increases the risk of complications or long-term infection, frequently resulting in amputations.
The project aims to develop a clinic-ready, safe, cost-effective and comprehensive wound-care dressing designed to prevent infection and accelerate the wound-healing process for diabetic foot ulcer patients. The core technology comprises of a biocompatible five-layer cloth. The patent-pending composite configurations absorb large amounts of fluid waste while maintaining porosity throughout. The product is cost-effective, safely absorbs large amounts of exudate, and maintains a moist and oxygenated environment for accelerated healing, while protecting the wound from external pathogens.
Point-of-care diagnostics for multiple diseases is extremely important, especially for resource challenged areas and existing solutions are expensive and limited.
The Team proposes developing a lab-on-a-strip (LOS) to enable chemical analysis for multiple tests, on a low-cost screen-printed electrode for Hb and Serum Albumin test for Anemia and Malnutrition screening; Serum Albumin and Glycated Albumin test for Advanced Diabetic Nephropathy management; and, Microalbminuria and Urine Creatinine test for early screening of Chronic Kidney Disease. The price point of the proposed LOS would be 70% lesser than what pathologists are charging currently for similar tests.